Endocrine Abstracts

Objective: Cushing’s disease (CD) accounts for approximately 80% of cases of Cushing’s syndrome. Diagnosis of CD is difficult, it is carried out with a screening test and confirmation test. The aim of this study is to describe the diagnostic results of the different diagnostic tests used in the diagnosis of CD in our environment.Patients and methods: Retrospective descriptive study of patients with CD. We included all patients diagnosed with CD...

Aim: Evaluate results of bariatric surgery by using the Bariatric analysis and reporting outcome system (BAROS) scoring systemPatients and methods: Observational clinical study of consecutive cases of patients undergoing bariatric surgery in Reina Sofia University Hospital (Córdoba, Spain) and clinical follow-up in the Endocrinology service between January and December 2018. Statistical analysis performed with SPSS 24th version.<p class="abstext...

Objectives: To describe modifiable sociodemographic and clinical risk factors predictive of severe hypoglycemia with need for urgent health care in adults with type 1 diabetes (T1DM).Methods: Multicenter, observational and retrospective study with case-control design.Cases: T1DM adults with severe hypoglycemia, defined as glycemia <70 mg/dl requiring urgent out-of-hospital health care for its resolution. Data source, geographic...

Introduction: Recent studies defend the measurements of insulin resistance and β-cell function to assess the endocrine pancreatic function in patients with cystic fibrosis (CF). HOMA-IR indexes greater than 1 translate insulin resistance and HOMA-%β values lower than 100% imply an altered β-cell function.Aim: To describe insulin resistance and β-cell function using HOMA-IR and HOMA-%β indexes in patients with CF and compare them ...

Aim: Describe the control of cardiovascular risk factors (CVRF) in patients with diabetes and myocardial infarction (MI) as well as their treatment and control.Patients and methods: Observational retrospective study of a cohort of patients with diabetes admitted to the cardiology department because of a MI between November 2015 and November 2016. Statistical analysis performed with SPSS 24th version.Results: 421 patients admitted b...

Introduction: Flash glucose monitoring (FGM) allows non-invasive glucose level assessment. Studies have shown that patients using FGM test their glucose levels more often than those who use traditional blood glucose testing. Given that a higher rate of glucose testing has showed to improve glycemic control our objective was to describe the change in the glycemic control and time in euglycemic range in patients with FGM and the effect of the number of scans in this control....

Introduction: Fine-needle aspiration (FNA) is indicated in suspicious thyroid nodules or big ones. Bethesda system classifies them according to the cytological malignancy risk. Bethesda category 4 (B4) comprises follicular neoplasms and suspicious follicular neoplasms. Aim: Determine final diagnosis of B4 nodules and study associations between malignancy and other variables.Methods: Retrospective study of patients with nodules classified as B4 a...

Introduction: Strokes are common diabetes macrovascular complications. A good control of cardiovascular risk factors such as glycemic control has been proven to reduce the risk of its appearance. Aim: Describe diabetes prevalence in patients admitted to hospital because of a stroke, as well as their treatment and metabolic control.Patients and methods: Observational retrospective study of patients admitted to the Neurology section because of a s...

Background: The complex involvement of multiple metabolic defects in the pathogenesis of type 2 diabetes mellitus (T2DM) makes difficult the treatment in monotherapy, therefore, the use of different antidiabetic drugs with different and complementary mechanisms of action could result in better glycemic control with favorable metabolic changes.Objective: To determine the effectiveness and safety of the addition of a sodium-glucose co-transporter type 2 in...

Background: Cross-sex hormone therapy (CHT) is known to lead to alterations in cardiovascular risk factor(CVRF).Objective: To assess changes in lipid profile and other CVRF in transsexual subjects receiving CHT.Materials and methods: Retrospective longitudinal study. We evaluated individuals with gender identity disorder following CHT, assisted in the Gender Identity Unit from 2015 to 2017. Primary endpoint was lipid profile change...